Immediate Impact
46 standout
Citing Papers
CAR T therapies in multiple myeloma: unleashing the future
2024 Standout
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
2024 Standout
Works of Diana Libster being referenced
Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective ofCD 38 expression and is related to dismal prognosis
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Diana Libster | 116 | 183 | 69 | 77 | 16 | 294 | |
| Jennifer L. Cultrera | 199 | 180 | 76 | 24 | 23 | 318 | |
| Olivia Minelli | 121 | 196 | 102 | 70 | 12 | 324 | |
| R Hoyt | 89 | 111 | 89 | 124 | 13 | 296 | |
| Catherine Burton | 87 | 144 | 54 | 38 | 16 | 237 | |
| Giovanni Frezza | 100 | 167 | 62 | 28 | 16 | 321 | |
| Claudia Castañeda | 153 | 98 | 29 | 49 | 15 | 231 | |
| Annalisa Gabriele | 111 | 253 | 85 | 24 | 12 | 308 | |
| G Brittinger | 81 | 144 | 66 | 36 | 22 | 250 | |
| R. Tubbs | 111 | 116 | 49 | 36 | 13 | 321 | |
| Florence Broussais‐Guillaumot | 149 | 222 | 91 | 45 | 14 | 298 |
All Works
Loading papers...